Efficacy of EGFR-TKIs Targeted Therapy as Adjuvant Systemic Treatment for Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis [30]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.